GlassScriptPhysician profile
Stephen Ward Etheredge
NPI 1629212972
$2,138.86
in general payments reported to CMS, 2019-2025
13 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $349 · 2021: $539 · 2022: $206 · 2023: $155 · 2024: $102 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $349.74 | 2019-2025 | Monovisc |
| Ferring Pharmaceuticals INC. | $338.69 | 2019-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $326.00 | 2019-2021 | |
| Horizon Therapeutics Plc | $236.16 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $225.76 | 2020-2025 | Iovera, Exparel, Zilretta |
| Sanofi-Aventis U.S. LLC | $150.11 | 2019-2023 | |
| Bioventus LLC | $130.84 | 2019-2025 | Durolane, Xcell |
| Fidia Pharma USA INC. | $119.36 | 2019-2022 | |
| Organogenesis INC. | $109.52 | 2019 | |
| Boston Scientific Corporation | $81.55 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $30.70 | 2024-2025 | |
| Alon Medical Technology | $26.92 | 2023 | |
| Pfizer INC. | $13.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Etheredge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.